Jan-08-21 Downgrade
BMO Capital Markets
Market Perform → Underperform
$49
Jan-06-21 Initiated
Robert W. Baird
Neutral
$49
Nov-30-20 Upgrade
BofA Securities
Underperform → Buy
Nov-10-20 Upgrade
Jefferies
Underperform → Hold
$50
Sep-08-20 Downgrade
Argus
Buy → Hold
Sep-02-20 Resumed
Stifel
Hold
$43
Aug-20-20 Downgrade
Raymond James
Strong Buy → Outperform
$45
Aug-14-20 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$34 → $45
Aug-14-20 Upgrade
Evercore ISI
Underperform → In-line
$43
Jun-15-20 Downgrade
Evercore ISI
In-line → Underperform
Mar-25-20 Upgrade
Raymond James
Mkt Perform → Strong Buy
$43
Mar-23-20 Downgrade
BofA/Merrill
Neutral → Underperform
Mar-10-20 Downgrade
Jefferies
Buy → Underperform
$36
Feb-28-20 Upgrade
Raymond James
Underperform → Mkt Perform
Jan-22-20 Downgrade
Raymond James
Mkt Perform → Underperform
Jan-17-20 Upgrade
Jefferies
Hold → Buy
$62 → $68
Dec-20-19 Resumed
Mizuho
Neutral
Dec-10-19 Downgrade
Wells Fargo
Market Perform → Underperform
$56
Nov-19-19 Upgrade
Argus
Hold → Buy
$67
Oct-30-19 Downgrade
Stifel
Buy → Hold
$74 → $66
Apr-15-21 04:51PM
Apr-13-21 09:30PM
Apr-08-21 12:05PM
Mar-30-21 11:36AM
Mar-20-21 11:30AM
Mar-18-21 07:35AM
Mar-17-21 06:23PM
Mar-05-21 04:44PM
Mar-04-21 04:00PM
Feb-26-21 11:53AM
Feb-18-21 08:31PM
07:45AM
06:55AM
Feb-04-21 06:55AM
Feb-02-21 06:55AM
Feb-01-21 06:55AM
Jan-28-21 06:55AM
Jan-27-21 09:17PM
Jan-24-21 01:00PM
Jan-20-21 06:55AM
Jan-16-21 11:05PM
Dec-22-20 09:53AM
Dec-18-20 08:00AM
04:46AM
Dec-16-20 10:46AM
Dec-11-20 06:55AM
Dec-10-20 01:00PM
Dec-06-20 11:30AM
Dec-05-20 09:00AM
Dec-01-20 04:32PM
Nov-30-20 11:58AM
10:00AM
Nov-18-20 05:05PM
Nov-16-20 03:20PM
Nov-10-20 05:00PM
Nov-09-20 12:33PM
10:00AM
Nov-06-20 09:30PM
11:40AM
09:06AM
08:15AM
07:01AM
06:59AM
Nov-05-20 10:41AM
10:15AM
09:47AM
06:04AM
Nov-04-20 10:15AM
Nov-02-20 11:00AM
Oct-27-20 10:50AM
Oct-22-20 08:41AM
Oct-21-20 05:00PM
Oct-20-20 04:52PM
Oct-15-20 07:00PM
Oct-07-20 11:40AM
Oct-06-20 06:08PM
Sep-30-20 06:55AM
Sep-23-20 08:35AM
Sep-22-20 02:05PM
Sep-18-20 06:55AM
Sep-14-20 05:18PM
Sep-07-20 08:00PM
Sep-06-20 11:30AM
Sep-03-20 06:27PM
Aug-25-20 01:42PM
09:30AM
Aug-21-20 09:18AM
Aug-17-20 01:43PM
Aug-14-20 09:34AM
Aug-13-20 04:15PM
Aug-07-20 08:27AM
08:25AM
06:55AM
Aug-06-20 10:34AM
08:41AM
Aug-05-20 06:00AM
Jul-27-20 03:06PM
07:30AM
Jul-25-20 09:09AM
Jul-23-20 07:30AM
Jul-22-20 07:50AM
Jul-20-20 11:07AM
Jul-10-20 06:00AM
Jul-06-20 08:04PM
05:18PM
Jul-02-20 01:23PM
Jun-19-20 07:39AM
Jun-16-20 04:30PM
Jun-15-20 09:17AM
08:55AM
Jun-12-20 12:28PM
Jun-09-20 07:50AM
Jun-07-20 11:30AM
Jun-01-20 01:45PM
May-23-20 11:30AM
May-22-20 09:45AM
May-14-20 07:21AM
May-11-20 06:52PM Thomson Reuters StreetEvents
May-08-20 04:57PM
03:30PM
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries A healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
CAFARO DEBRA A Chairman and CEO Apr 01 Option Exercise 46.88 18,076 847,403 759,352 Apr 02 04:18 PM CAFARO DEBRA A Chairman and CEO Apr 01 Sale 53.33 18,076 964,071 741,276 Apr 02 04:18 PM GILCHRIST RICHARD I Director Mar 24 Option Exercise 46.02 8,934 411,124 41,210 Mar 26 05:29 PM GILCHRIST RICHARD I Director Mar 24 Sale 54.04 8,934 482,792 35,270 Mar 26 05:29 PM Probst Robert F EVP and CFO Mar 11 Sale 58.00 5,100 295,800 141,506 Mar 12 04:55 PM CAFARO DEBRA A Chairman and CEO Mar 01 Option Exercise 46.88 18,076 847,403 759,352 Mar 03 05:01 PM CAFARO DEBRA A Chairman and CEO Mar 01 Sale 53.77 18,076 972,031 741,276 Mar 03 05:01 PM Liebbe Gregory R SVP, Chief Accounting Officer Feb 26 Sale 54.04 3,700 199,948 9,869 Feb 26 05:57 PM Probst Robert F EVP and CFO Feb 22 Sale 54.00 5,200 280,800 142,591 Feb 23 07:12 PM CAFARO DEBRA A Chairman and CEO Feb 01 Option Exercise 46.88 18,076 847,403 753,691 Feb 02 05:29 PM CAFARO DEBRA A Chairman and CEO Feb 01 Sale 47.05 18,076 850,505 735,615 Feb 02 05:29 PM GELLERT JAY M Director Dec 18 Option Exercise 44.17 5,940 262,370 174,251 Dec 21 04:40 PM Probst Robert F EVP and CFO Nov 24 Sale 50.00 5,500 275,000 78,740 Nov 25 05:02 PM SHELTON JAMES D Director Nov 12 Option Exercise 44.17 5,940 262,370 59,644 Nov 16 04:16 PM Reed Robert D. Director Nov 12 Option Exercise 44.17 5,940 262,370 58,389 Nov 16 04:16 PM Reed Robert D. Director Nov 12 Sale 47.77 5,940 283,739 52,449 Nov 16 04:16 PM SHELTON JAMES D Director Nov 12 Sale 47.83 5,940 284,095 53,704 Nov 16 04:16 PM Probst Robert F EVP and CFO Aug 11 Sale 42.20 16,000 675,206 84,240 Aug 12 06:16 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite